138 related articles for article (PubMed ID: 36748382)
1. Influencing factors and risk prediction model for cervical cancer recurrence.
Li J; Luo J; Liu G; Yan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1711-1720. PubMed ID: 36748382
[TBL] [Abstract][Full Text] [Related]
2. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
Xie G; Wang R; Shang L; Qi C; Yang L; Huang L; Yang W; Chung MC
BMC Cancer; 2020 Sep; 20(1):833. PubMed ID: 32873257
[TBL] [Abstract][Full Text] [Related]
3. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
5. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
7. Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.
Li J; Liu G; Luo J; Yan S; Ye P; Wang J; Luo M
Sci Rep; 2022 Aug; 12(1):13994. PubMed ID: 35978078
[TBL] [Abstract][Full Text] [Related]
8. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a nomogram for progression to diabetic foot ulcers in elderly diabetic patients.
Shao Z; Wang Z; Bi S; Zhang J
Front Endocrinol (Lausanne); 2023; 14():1107830. PubMed ID: 37082126
[TBL] [Abstract][Full Text] [Related]
10. The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB-IVA cervical cancer.
Deng C; Ding D; Wang M
Postgrad Med; 2021 May; 133(4):436-443. PubMed ID: 33620285
[No Abstract] [Full Text] [Related]
11. [Analysis of prognosis and influencing factors of No. 253 lymph node metastasis in descending colon, sigmoid colon, and rectal cancer: a multicenter study].
Zhao FQ; Zhou L; Du XH; Wu AW; Yang H; Xu L; Liu XZ; Hu SD; Xiao Y; Liu Q
Zhonghua Wai Ke Za Zhi; 2023 Sep; 61(9):760-767. PubMed ID: 37491168
[No Abstract] [Full Text] [Related]
12. Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study.
Jiao S; Guo L; Da F; Gao Q; Ren Z; Wang J; Fu Q; Liu J
Technol Cancer Res Treat; 2023; 22():15330338231164191. PubMed ID: 37078156
[No Abstract] [Full Text] [Related]
13. Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study.
Liu J; Li S; Cao Q; Zhang Y; Nickel MD; Zhu J; Cheng J
Ann Surg Oncol; 2023 Sep; 30(9):5577-5585. PubMed ID: 37355522
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
15. Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
Park JY; Chong GO; Park JY; Chung D; Lee YH; Lee HJ; Hong DG; Han HS; Lee YS
Gynecol Oncol; 2020 Oct; 159(1):157-163. PubMed ID: 32741542
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram model for predicting clinical pregnancy in endometriosis patients undergoing fresh embryo transfer.
Zhu S; Liao X; Jiang W; Sun Y; Chen X; Zheng B
BMC Pregnancy Childbirth; 2023 Oct; 23(1):764. PubMed ID: 37907870
[TBL] [Abstract][Full Text] [Related]
17. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
[TBL] [Abstract][Full Text] [Related]
18. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
[No Abstract] [Full Text] [Related]
19. Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
Wu J; Wang R; Chen W; Wu Y; Xiao L
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
